SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-232800
Filing Date
2022-08-29
Accepted
2022-08-29 16:31:22
Documents
68
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 6-K d386235d6k.htm   iXBRL 6-K 139899
2 EX-99.1 d386235dex991.htm   iXBRL EX-99.1 813984
  Complete submission text file 0001193125-22-232800.txt   5776380

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amam-20220630.xsd EX-101.SCH 53547
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amam-20220630_cal.xml EX-101.CAL 45385
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amam-20220630_def.xml EX-101.DEF 296668
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE amam-20220630_lab.xml EX-101.LAB 387525
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amam-20220630_pre.xml EX-101.PRE 349363
62 EXTRACTED XBRL INSTANCE DOCUMENT d386235d6k_htm.xml XML 990671
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 729-3339
Ambrx Biopharma Inc. (Filer) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40505 | Film No.: 221211646
SIC: 2836 Biological Products, (No Diagnostic Substances)